Off-label Marketing

Off-Label Marketing is a regulatory and legal concept in pharmaceutical law denoting the promotion of a drug for uses, patient populations, or dosages not approved by the relevant regulatory authority, thereby distinguishing it from approved, labeling-compliant marketing practices.

22

Publications

816

Citations

42

Authors

30

Institutions

Publications per year

2017–2026

6

Authors

42

  1. AS
    Aaron S. Kesselheim

    Brigham and Women's Hospital, United States

    4 publications · 275 citations

    4

    h-index

  2. JA
    Jerry Avorn

    Brigham and Women's Hospital, United States

    3 publications · 163 citations

    3

    h-index

  3. DM
    David M. Studdert

    The University of Melbourne, Australia

    3 publications · 223 citations

    3

    h-index

  4. SM
    Shai Mulinari

    Lund University, Sweden

    2 publications · 63 citations

    2

    h-index

  5. CD
    Courtney Davis

    King's College London, United Kingdom

    2 publications · 63 citations

    2

    h-index

1–5 of 42

Venues

  1. PLoS Medicine

    4 publications · 302 citations

    4

    h-index

  2. Health Affairs

    2 publications · 90 citations

    2

    h-index

  3. Journal of Public Policy & Marketing

    JPP&M · 1 publications · 23 citations

    1

    h-index

  4. Sexualities

    1 publications · 51 citations

    1

    h-index

  5. JAMA Internal Medicine

    1 publications · 31 citations

    1

    h-index

1–5